Read More Pharma Industry News ImmunogenX enrolls patients for Solutions for Celiac trial of Latiglutenase ImmunogenX, a subsidiary of Immunogenics, has started enrollment of patients for a phase 2b clinical trial to evaluate… bypharmanewsdailyFebruary 14, 2020
